AIMS
SF Journal of Hematology and Oncology aims to provide a multidisciplinary forum for research concerning disorders of the blood, blood-forming organs, and malignant diseases. The journal welcomes studies addressing hematological disorders, leukemia, lymphoma, myeloma, solid tumors, cancer biology, hematopathology, molecular oncology, cancer biomarkers, chemotherapy, targeted and immunological therapies, supportive care, and advances in cancer diagnosis, prevention, treatment, and survivorship.
SCOPE
Publishes research on hematological disorders, leukemia, lymphoma, myeloma, solid tumors, cancer biology, biomarkers, and emerging cancer therapies.
RESEARCH AREAS
Hematology; Hematological Disorders; Leukemia; Lymphoma; Multiple Myeloma; Solid Tumors; Cancer Biology; Hematopathology; Molecular Oncology; Cancer Biomarkers; Immunotherapy; Targeted Cancer Therapy
ARTICLE TYPES
Original Research Articles; Review Articles; Clinical Studies; Case Reports; Case Series; Short Communications; Clinical Trials
TOPICS COVERED
Hematology
Oncology
Hematologic Malignancies
Leukemia
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
Anemia
Thrombocytopenia
Hemostasis
Coagulation Disorders
Thrombosis
Blood Transfusion
Hematopoietic Stem Cells
Stem Cell Transplantation
Bone Marrow Disorders
Immunohematology
Molecular Hematology
Hematopathology
Cancer Biology
Cancer Genetics
Cancer Immunology
Tumor Biology
Targeted Therapy
Immunotherapy
Chemotherapy
Precision Oncology
Supportive Oncology
Translational Oncology